ELIQUIS 5 mg/1

ELIQUIS 5 mg/1 is an oral medication containing apixaban, used for managing blood clots and reducing stroke risk. This film-coated tablet is manufactured by E.R. Squibb & Sons, L.L.C. in the USA.

ELIQUIS 5 mg/1 is commonly prescribed to prevent and treat blood clots in the veins, known as deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to reduce the risk of stroke in patients with atrial fibrillation, a condition characterized by an irregular heartbeat. Apixaban works by inhibiting certain clotting factors in the blood, helping to maintain proper blood flow.

Common effects of ELIQUIS 5 mg/1 may include minor bleeding, bruising, and gastrointestinal discomfort. Some users might experience dizziness or fatigue. It is important to consult a healthcare provider if any adverse effects persist or worsen.

ELIQUIS 5 mg/1 should be handled with care, especially by individuals with a history of bleeding disorders or those taking other blood-thinning medications. It is crucial to follow the prescribed dosage and storage instructions. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

ELIQUIS 5 mg/1 may interact with certain medications, including other blood thinners, antiplatelet drugs, and some antibiotics. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication while taking ELIQUIS.